Berberine ameliorates the progression of primary sclerosing cholangitis by activating farnesoid X receptor
Cell Biochemistry and Biophysics · 2024-06 · 82 (2) · 767-776
DOI: 10.1007/s12013-024-01226-8 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cell Biochemistry and Biophysics, online erschienen am 08.02.2024. Verfasst von Hassan Hameed und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Zoology, Government College University Lahore, Lahore, Pakistan. Hauptthemen laut MEDLINE: Berberine, Cholangitis, Sclerosing, Receptors, Cytoplasmic and Nuclear, Liver. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 49 Literaturangaben.
Abstract (Originalsprache)
Primary sclerosing cholangitis (PSC) is a rare cholestatic disease characterized by biliary infiltration, hepatic fibrosis and bile duct destruction. To date, treatment options for PSC are very limited. Therefore, the current study is aimed to investigate the therapeutic potential of berberine (BBR) against PSC. The disease was induced by feeding the mice with 3,5-diethoxycarbonyl-1,4-dihydro-2,4,6-collidine (DDC) for four weeks. The serum biochemistry and liver histology were analyzed. Furthermore, the expression of farnesoid X receptor (FXR) was also evaluated by real-time PCR. The results indicated that berberine prevents the progression of PSC by modulating the expression of FXR which ultimately regulates other genes (including Cyp7A1 and BSEP) thus maintaining bile acids homeostasis. Furthermore, the docking analysis showed that berberine interacts with the binding pocket of FXR to activate the protein thus acting as an FXR agonist. In conclusion, data indicate that berberine protects the liver from PSC-related injury. This effect might be due to the modulation of FXR activity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Zoology, Government College University Lahore, Lahore, Pakistan.
- Section of Biology and Genetics, Department of Neurosciences, Biomedicine and Movement Sciences, University of Verona, Verona, Italy.
- Department of Zoology, Government College University Lahore, Lahore, Pakistan. imransohail@gcu.edu.pk.
Zitieren
APA
Hameed, H., Irshad, N., Yousaf, M. A., Mumtaz, S., & Sohail, I. (2024). Berberine ameliorates the progression of primary sclerosing cholangitis by activating farnesoid X receptor. Cell Biochemistry and Biophysics, 82(2), 767-776. https://doi.org/10.1007/s12013-024-01226-8
Vancouver
Hameed H, Irshad N, Yousaf MA, Mumtaz S, Sohail I. Berberine ameliorates the progression of primary sclerosing cholangitis by activating farnesoid X receptor. Cell Biochemistry and Biophysics. 2024;82(2):767-776. doi:10.1007/s12013-024-01226-8
BibTeX
@article{Hameed2024,
author = {Hameed, Hassan and Irshad, Nida and Yousaf, Muhammad Abrar and Mumtaz, Sidra and Sohail, Imran},
title = {Berberine ameliorates the progression of primary sclerosing cholangitis by activating farnesoid X receptor},
journal = {Cell Biochemistry and Biophysics},
year = {2024},
volume = {82},
number = {2},
pages = {767--776},
doi = {10.1007/s12013-024-01226-8}
}
EUVIMED